Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cotara in Recurrent Glioblastoma Multiforme
NCT00677716Phase 2Completed
- Sponsor
- Avid Bioservices, Inc.
- Start
- Jul 2007
- Primary completion
- Sep 2011
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of iodine-131-chTNT in glioblastoma multiforme (GBM), sponsored by Avid Bioservices, Inc.. Started Jul 2007; status: completed.
02
Drugs
iodine-131-chTNT
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00677716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00677716.